Verrica Pharmaceuticals Inc.VRCANASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-65.90M
↓ 116% below average
Average (8y)
$-30.49M
Historical baseline
Range
High:$-1.91M
Low:$-65.90M
CAGR
+55.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-65.90M | -6.0% |
| 2023 | $-62.20M | -188.0% |
| 2022 | $-21.60M | +28.8% |
| 2021 | $-30.31M | +23.1% |
| 2020 | $-39.43M | -41.1% |
| 2019 | $-27.95M | -35.5% |
| 2018 | $-20.63M | -362.8% |
| 2017 | $-4.46M | -133.0% |
| 2016 | $-1.91M | - |